2018 Annual Meeting | C63 - Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis

Date Monday 04/23/18

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Michael D. Weiss, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the current management of ALS, inflammatory neuropathies and myopathies, and myasthenia gravis.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:25 AM	Speaker	Treatment of Amyotrophic Lateral Sclerosis Michael D. Weiss, MD, FAAN
07:25 AM - 07:30 AM	Q&A	Questions and Answers Michael D. Weiss, MD, FAAN
07:30 AM - 07:55 AM	Speaker	Treatment of Inflammatory Neuropathies Michael D. Weiss, MD, FAAN
07:55 AM - 08:00 AM	Q&A	Questions and Answers Michael D. Weiss, MD, FAAN
08:00 AM - 08:25 AM	Speaker	Treatment of Myasthenia Gravis Anthony A. Amato, MD, FAAN
08:25 AM - 08:50 AM	Speaker	Treatment of Inflammatory Myopathies Anthony A. Amato, MD, FAAN
08:50 AM - 09:00 AM	Q&A	Questions and Answers Anthony A. Amato, MD, FAAN

Faculty Disclosures
Michael D. Weiss, MD, FAAN	Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Anthony A. Amato, MD, FAAN	Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abscuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.